Understanding how breast cancer begins

Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.
Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI

Understanding how breast cancer begins

July 1, 2026
Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.
Read Transcript

The challenge 

Around 1 in 400 people worldwide carry a BRCA1 or BRCA2 gene mutation, increasing their lifetime risk of developing breast cancer. For women who carry a BRCA1 mutation, up to 65% will develop breast cancer by age 80, while the risk is around 45% for women with a BRCA2 mutation. Because of this high risk, many women choose preventative surgery to reduce their risk of developing breast or ovarian cancer. Others undergo regular screening to help ensure cancer can be detected as early as possible.

Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI are working to better understand how healthy cells become cancerous in people who carry BRCA mutations. Their goal is to generate the knowledge needed to develop new approaches that could one day prevent breast cancer without needing life-altering surgery.

The role of philanthropy

Hearts & Minds funding, as nominated by Cooper Investors, enabled this project to get underway and has since helped researchers secure an additional $186,000 in funding to expand the work.

To understand how breast cancer begins, researchers are using unique barcodes to track individual breast cells over time, revealing the changes that occur as healthy cells progress towards cancer. By mapping these early changes, the team hopes to identify new opportunities to intervene before cancer develops. Although the project is still in its early stages, researchers have already introduced around 2,000 unique barcodes into thousands of breast cells and are now using these models to study how cells evolve.

What this could unlock

Professor Jane Visvader and Professor Geoff Lindeman’s vision is to give women with BRCA mutations more options beyond extensive, life-altering preventative surgeries, providing future generations with greater choice and peace of mind. Ultimately, researchers hope this work will lead to new treatments that could be tested in clinical trials, helping improve outcomes for people at higher risk of developing breast cancer.

This project is supported by Hearts and Minds Investments, as nominated by Cooper Investors. For further information and updates, visit WEHI.

The challenge 

Around 1 in 400 people worldwide carry a BRCA1 or BRCA2 gene mutation, increasing their lifetime risk of developing breast cancer. For women who carry a BRCA1 mutation, up to 65% will develop breast cancer by age 80, while the risk is around 45% for women with a BRCA2 mutation. Because of this high risk, many women choose preventative surgery to reduce their risk of developing breast or ovarian cancer. Others undergo regular screening to help ensure cancer can be detected as early as possible.

Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI are working to better understand how healthy cells become cancerous in people who carry BRCA mutations. Their goal is to generate the knowledge needed to develop new approaches that could one day prevent breast cancer without needing life-altering surgery.

The role of philanthropy

Hearts & Minds funding, as nominated by Cooper Investors, enabled this project to get underway and has since helped researchers secure an additional $186,000 in funding to expand the work.

To understand how breast cancer begins, researchers are using unique barcodes to track individual breast cells over time, revealing the changes that occur as healthy cells progress towards cancer. By mapping these early changes, the team hopes to identify new opportunities to intervene before cancer develops. Although the project is still in its early stages, researchers have already introduced around 2,000 unique barcodes into thousands of breast cells and are now using these models to study how cells evolve.

What this could unlock

Professor Jane Visvader and Professor Geoff Lindeman’s vision is to give women with BRCA mutations more options beyond extensive, life-altering preventative surgeries, providing future generations with greater choice and peace of mind. Ultimately, researchers hope this work will lead to new treatments that could be tested in clinical trials, helping improve outcomes for people at higher risk of developing breast cancer.

This project is supported by Hearts and Minds Investments, as nominated by Cooper Investors. For further information and updates, visit WEHI.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Picture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt Call
July 1, 2026

Next generation CAR T-cell therapy for cancer

The Call Lab at WEHI is pioneering innovative approaches to find this ‘goldilocks zone’, making CAR T-cell therapy safer and more effective.

Read More
Picture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale Cohen
July 1, 2026

Revolutionising Diabetes Care

Improving diabetes care has the potential to transform individual health outcomes while strengthening the wellbeing of entire communities.

Read More
HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).
May 4, 2026

How science turned back the clock of human development to create a miracle blood stem cell

Many thought it could never be done. But three Murdoch Children’s Research Institute scientists recreated embryonic development to crack the blood stem cell code.

Read More
November 15, 2024

Professor Alex Brown in conversation with Professor Jason Kovacic

At the 2024 Sohn Hearts & Minds Conference, we heard from Professor Alex Brown in conversation with Professor Jason Kovacic about Indigenous heart health and genomics.

Read More

A/Professor Tim Sargeant | 2024 Sohn Hearts & Minds Conference

Associate Professor Tim Sargeant has been at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide where he studies the role of lysosomes in Alzheimer’s disease.

Read More
July 1, 2026

Unlocking the mysteries of the human brain

The Sydney Brain Bank is helping researchers uncover the causes of neurodegenerative disease and build a future with better diagnosis, treatment and prevention.

Read More
Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.
July 1, 2026

A new approach to Parkinson’s Disease

Exploring nerve stimulation as a potential treatment.

Read More
Dr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds Conference
July 1, 2026

Revealing what drives PSP

Mapping the biological changes behind progressive supranuclear palsy in the brain.

Read More
Picture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer Snaith
July 1, 2026

Advancing treatment options for type 1 diabetes

Improving blood glucose and reducing insulin needs.

Read More
Picture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish King
July 1, 2026

Solving the genetic causes of autoimmune diseases

Mapping hundreds of risk markers to better understand how these diseases develop and progress

Read More
July 1, 2026

The Future of Pain Management

Enhancing healthcare professionals' ability to deliver better pain management, now and into the future.

Read More
July 1, 2026

Harnessing the power of stem cell technology

Developing cell therapies for patients with blood diseases

Read More
Picture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki Negishi
July 1, 2026

Protecting the heart when every minute matters

Investigating a new treatment to reduce heart damage after heart attacks

Read More
Picture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio Vittorio
July 1, 2026

Targeting the drivers of cancer growth

Exploring how extrachromosomal DNA (ecDNA) drives cancer growth, spread and treatment resistance.

Read More
July 1, 2026

Improving the diagnosis of muscle disorders using advanced genetic testing

Focused on improving the efficiency and accuracy of diagnosing muscle disorders.

Read More